To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.

NCT03001726 · clinicaltrials.gov ↗

UNKNOWN

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

PROCEDURE: Gastrectomy
DRUG: oxaliplatin
DRUG: S1
DRUG: Docetaxel

Sponsor

Shanghai Zhongshan Hospital